It is clear is that the FTC has fully entered the CBD regulatory space and we can expect to hear more from it during the coming months.
Category: Industry Sector
Legal Cannabis is a Huge Job Creation Machine (Guest Post)
Jobs in the legal cannabis industry are coming by the hundreds of thousands and there’s no sign of that halting.
FDA and AHPA Convey Similar Message to Cannabis and CBD Industry
The “wild west” days of manufacturing and selling cannabis products outside the sphere of regulatory influence are rapidly coming to an end.
New “Hemp For Victory” Bill Promises to Revolutionize Hemp
There is really no portion of American life that the Hemp for Victory bill does not touch. It seeks to study the potential uses of hemp across all sectors of our economy.
FDA Issues CBD Warning Letter to Curaleaf
Regardless of how the FDA will eventually regulate CBD, it is abundantly clear that CBD companies should not make medical/disease claims nor market their products as dietary supplements. Doing so at this point is simply foolish.
Smokable Hemp Sparks a Firestorm
This article discusses the reasons for smokable hemp’s rapid rise in popularity, why the future of smokable hemp is vital to the hemp industry at large, and the ways in which its legal status is under attack in several states.
USDA Created a Regulatory Vacuum. States Are Beginning to Fill It.
The entire hemp industry is anxiously awaiting guidance from the United States Department of Agriculture (USDA). This wait has created a vacuum of sorts that many state legislatures are beginning to fill.
Nevada Law Will Protect Employees Who Use Marijuana (Guest Post)
Employers in most states still have the right to discriminate against cannabis users in pre-employment drug screenings. The exception is the state of Nevada, which passed legislation banning the disqualification of a candidate for employment based on cannabis use.
FDA Wants Your Comments on CBD
As anyone involved in the cannabis industry is aware, the US Food and Drug Administration (FDA) held hearings on May 31, 2019. Ostensibly, the hearing was about “Products Containing Cannabis or Cannabis-Derived Compounds”. In reality, it was about cannabidiol (CBD) in foods, cosmetics, and dietary supplements.